SUPARTZ
FDA premarket approval P980044/S006 · decided 2007-03-07
Approval details
- PMA number
- P980044
- Supplement
- S006
- Supplement type
- Special (Immediate Track)
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- SUPARTZ
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Seikagaku Corp.
- Date received
- 2007-01-30
- Decision date
- 2007-03-07
- Days to decision
- 36 days
- Decision code
- APPR
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Tokyo
- Statement
- APPROVAL FOR ADDING BOTH POSSIBLE ADVERSE REACTIONS REPORTED WORLDWIDE TO THE INSTRUCTION FOR USE, AND THE POSSIBLE SIDE EFFECTS COLLECTED FROM WORLDWIDE POST-MARKET EXPERIENCE TO THE PATIENT INFORMATION BROCHURE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| HADGEL, 4 GRAM/SYRINGE (K011544) | Seikagaku Corp. | 2001-08-15 |